Moolec Science (MLEC) FCF Payout Ratio (2023 - 2024)
Moolec Science (MLEC) reported FCF Payout Ratio of 0.04 for Q4 2024, up 45.24% on a YoY basis from 0.03 in Q1 2024, and up 45.24% sequentially from 0.07 in Q4 2023.
Moolec Science (MLEC) FCF Payout Ratio (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of FCF Payout Ratio data on file, last reported at 0.04 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.12 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.04 |
| Dec 31, 2023 | -0.07 |